Results 11 to 20 of about 2,930,894 (275)
SAGE Open Medical Case Reports, 2017 Context: Immunoglobulin G2 deficiency that persists beyond the age of 6 years is likely to be permanent. Case report: We report on a young Japanese female, diagnosed as having immunoglobulin G2 deficiency and low anti-pneumococcal immunoglobulin G2 ...
Masayoshi Shinjoh +3 more
doaj +2 more sources
Therapeutics and Clinical Risk Management, 2009 Suzanne Skoda-Smith, Troy R Torgerson, Hans D OchsSeattle Children’s Research Institute and Department of Pediatrics, University of Washington, Seattle, WashingtonAbstract: Antibody deficiency is the most frequently encountered primary ...
Suzanne Skoda-Smith +2 more
doaj +1 more source
Immunoglobulin replacement therapies in inborn errors of immunity: a review
Frontiers in PediatricsImmunoglobulins (Ig) were used as a therapeutic modality for the first time in a patient with X-linked agammaglobulinemia in 1952 by Colonel Ogden Bruton, decades before the molecular mechanisms causing the disease were unraveled.
Archan Sil +7 more
doaj +3 more sources
Human normal immunoglobulin in the treatment of primary immunodeficiency diseases [PDF]
Therapeutics and Clinical Risk Management, 2012 Philip WoodSt James University Hospital, Leeds, United KingdomAbstract: The primary antibody deficiency syndromes are a rare group of disorders that can present at any age, and for which delay in diagnosis remains common.
Wood P
doaj +1 more source
Biologics: Targets & Therapy, 2012 Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s, replacement of immunoglobulin G using human immunoglobulin has been the standard treatment for primary immunodeficiency diseases with defects in antibody
Kobrynski L
doaj +1 more source
Hormone replacement therapy is associated with improved verbal declarative memory in healthy relatively recent postmenopausal women. [PDF]
, 2006 The efficacy of Hormone Replacement Therapy (HRT) for cognitive health in postmenopausal women has been systematically questioned during the last decade.
Sünram-Lea, Sandra I. +3 more
core +5 more sources
Frontiers in Oncology, 2023 Chronic lymphocytic leukaemia (CLL) is a malignancy of clonally expanded antigen-switched, neoplastic, mature B cells. CLL is characterised by a variable degree of immunosuppression and secondary hypogammaglobulinemia.
Sujoy Khan +3 more
doaj +1 more source
Trends in Pediatrics, 2023 Objective: In a large group of patients with primary immunodeficiency (PID), immunoglobulin replacement therapy is critical for infection control. There are two main methods of immunoglobulin replacement intravenous (IVIG) and subcutaneous (SCIG).
Selime Özen Bölük +9 more
doaj +1 more source
Treatment of patients with immunodeficiency: Medication, gene therapy, and transplantation
Jornal de Pediatria, 2021 Objectives: To provide an overview of drug treatment, transplantation, and gene therapy for patients with primary immunodeficiencies. Source of data: Non-systematic review of the literature in the English language carried out at PubMed. Synthesis of data:
Gesmar Rodrigues Silva Segundo +1 more
doaj +1 more source
Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study [PDF]
Frontiers in ImmunologySánchez-Ramón Silvia +2 more
exaly +2 more sources